Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2350664
Title:
TRAITEMENT DU CANCER À L'AIDE DU PROMÉDICAMENT ACTIVÉ PAR L'HYPOXIE TH-302 EN COMBINAISON AVEC LE DOCETAXEL OU LE PEMETREXED
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
098226574
WO application number:
US2009061541
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2350664
WO publication number:
WO2010048330
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
21/10/2009
Grant date:
19/05/2021
EP publication date:
03/08/2011
WO publication date:
29/04/2010
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
19/05/2021
EP B1 publication date:
19/05/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/10/2021
Expiration date (if granted and all annual fees paid):
21/10/2029
Applicant
Name:
ImmunoGenesis, Inc.
Legal Form:
From:
19/05/2021
Address:
909 Fannin St Suite 2000, Houston TX 77010, United States (US)
To:
Inventor
1
Name:
CURD, John G.
Legal Form:
Address:
Burlingame
California 94010, United States (US)
2
Name:
KROLL, Stewart
Legal Form:
Address:
Oakland
California 94618, United States (US)
3
Name:
MATTEUCCI, Mark
Legal Form:
Address:
Portola Valley
California 94028, United States (US)
4
Name:
HART, Charles P.
Legal Form:
Address:
Mountain View
California 94040, United States (US)